BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24766180)

  • 1. Palliative radiation therapy outcomes for cats with oral squamous cell carcinoma (1999-2005).
    Sabhlok A; Ayl R
    Vet Radiol Ultrasound; 2014; 55(5):565-70. PubMed ID: 24766180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of oral squamous cell carcinoma with accelerated radiation therapy and concomitant carboplatin in cats.
    Fidel J; Lyons J; Tripp C; Houston R; Wheeler B; Ruiz A
    J Vet Intern Med; 2011; 25(3):504-10. PubMed ID: 21539605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma.
    Jones PD; de Lorimier LP; Kitchell BE; Losonsky JM
    J Am Anim Hosp Assoc; 2003; 39(5):463-7. PubMed ID: 14518654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and toxicity of an accelerated hypofractionated radiation therapy protocol in cats with oral squamous cell carcinoma.
    Poirier VJ; Kaser-Hotz B; Vail DM; Straw RC
    Vet Radiol Ultrasound; 2013; 54(1):81-8. PubMed ID: 23078236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of feline oral squamous cell carcinoma to palliative radiation therapy.
    Bregazzi VS; LaRue SM; Powers BE; Fettman MJ; Ogilvie GK; Withrow SJ
    Vet Radiol Ultrasound; 2001; 42(1):77-9. PubMed ID: 11245242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and outcome in cats with oral squamous cell carcinoma after accelerated hypofractionated radiotherapy and concurrent systemic treatment.
    Marconato L; Weyland M; Tresch N; Rossi F; Leone V; Rohrer Bley C
    Vet Comp Oncol; 2020 Sep; 18(3):362-369. PubMed ID: 31756259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
    Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W
    Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nine-day accelerated radiation protocol for feline squamous cell carcinoma.
    Fidel JL; Sellon RK; Houston RK; Wheeler BA
    Vet Radiol Ultrasound; 2007; 48(5):482-5. PubMed ID: 17899987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for feline cutaneous squamous cell carcinoma using a hypofractionated protocol.
    Cunha SC; Carvalho LA; Canary PC; Reisner M; Corgozinho KB; Souza HJ; Ferreira AM
    J Feline Med Surg; 2010 Apr; 12(4):306-13. PubMed ID: 20034827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma.
    Wiles V; Hohenhaus A; Lamb K; Zaidi B; Camps-Palau M; Leibman N
    J Feline Med Surg; 2017 Feb; 19(2):185-193. PubMed ID: 26755491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of toceranib phosphate (Palladia) when used in conjunction with other therapies in 35 cats with feline oral squamous cell carcinoma: 2009-2013.
    Olmsted GA; Farrelly J; Post GS; Smith J
    J Feline Med Surg; 2017 Jun; 19(6):568-575. PubMed ID: 26951557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma.
    Evans SM; LaCreta F; Helfand S; VanWinkle T; Curran WJ; Brown DQ; Hanks G
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):703-8. PubMed ID: 1825993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.
    Fox LE; Rosenthal RC; King RR; Levine PB; Vail DM; Helfand SC; MacEwen EG; Perez-Soler R; Calderwood-Mays M; Kurzman ID
    Am J Vet Res; 2000 Jul; 61(7):791-5. PubMed ID: 10895902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma.
    Lundberg AP; Tran Hoang C; Billhymer A; Selting KA
    Vet Comp Oncol; 2022 Dec; 20(4):788-796. PubMed ID: 35561080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats: 49 cases (1990-2006).
    Hammond GM; Gordon IK; Theon AP; Kent MS
    J Am Vet Med Assoc; 2007 Sep; 231(5):736-41. PubMed ID: 17764434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of (90)Strontium plesiotherapy for feline squamous cell carcinoma of the nasal planum.
    Goodfellow M; Hayes A; Murphy S; Brearley M
    J Feline Med Surg; 2006 Jun; 8(3):169-76. PubMed ID: 16442824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamine inhibitors for treatment of feline oral squamous cell carcinoma: a proof-of-concept study.
    Lewis JR; O'Brien TG; Skorupski KA; Krick EL; Reiter AM; Jennings MW; Jurney CH; Shofer FS
    J Vet Dent; 2013; 30(3):140-5. PubMed ID: 24371920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy.
    Yoshikawa H; Ehrhart EJ; Charles JB; Custis JT; LaRue SM
    Vet Comp Oncol; 2016 Mar; 14(1):39-57. PubMed ID: 23815402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 90Sr therapy for oral squamous cell carcinoma in two cats.
    Nagata K; Selting KA; Cook CR; Renschler M; Lattimer JC
    Vet Radiol Ultrasound; 2011; 52(1):114-7. PubMed ID: 21322398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline Oral Squamous Cell Carcinoma: Clinical Manifestations and Literature Review.
    Bilgic O; Duda L; Sánchez MD; Lewis JR
    J Vet Dent; 2015; 32(1):30-40. PubMed ID: 26197688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.